Home › Trial NCT07562347
Clinical Experience and Real-world Safety and Effectiveness of Envafolimab: Patient Access Program
- Trial IDNCT07562347
- StatusNot Yet Recruiting
- PhaseN/A
- Study typeObservational
- SponsorIR INNOVATE RESEARCH PRIVATE LIMITED
- Enrollment120
- Start date2026-05
- ConditionsAdvanced Solid Tumor
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.